Brian Edward Miller - 11 Mar 2025 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Digital Officer
Signature
By: Stephanie Lim-Ignacio For: Miller, Brian Edward
Issuer symbol
ISRG
Transactions as of
11 Mar 2025
Net transactions value
-$5,251,230
Form type
4
Filing time
12 Mar 2025, 18:34:07 UTC
Previous filing
03 Mar 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $326,428 +1,834 +14% $177.99 14,658 11 Mar 2025 Direct F1
transaction ISRG Common Stock Sale $891,245 -1,834 -13% $485.96 12,824 11 Mar 2025 Direct F1, F2
transaction ISRG Common Stock Sale $213,408 -442 -3.4% $482.82 12,382 11 Mar 2025 Direct F1, F3
transaction ISRG Common Stock Sale $3,212,449 -6,624 -53% $484.97 5,758 11 Mar 2025 Direct F1, F4
transaction ISRG Common Stock Options Exercise $275,879 +1,550 +27% $177.99 7,308 12 Mar 2025 Direct F1
transaction ISRG Common Stock Sale $793,693 -1,550 -21% $512.06 5,758 12 Mar 2025 Direct F1
transaction ISRG Common Stock Options Exercise $511,805 +2,450 +43% $208.90 8,208 12 Mar 2025 Direct F1
transaction ISRG Common Stock Sale $1,254,547 -2,450 -30% $512.06 5,758 12 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,834 -54% $0.000000 1,550 11 Mar 2025 Common Stock 1,834 $177.99 Direct F1, F5
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,550 -100% $0.000000 0 12 Mar 2025 Common Stock 1,550 $177.99 Direct F1, F5
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,450 -36% $0.000000 4,317 12 Mar 2025 Common Stock 2,450 $208.90 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 10, 2025.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $479.78 to $489.50 as follows: 243 shares sold at $479.78 to $480.75; 200 shares sold at $480.99to $481.50; 100 shares sold at $483.59; 100 shares sold at $485.39; 791 shares sold at $487.20 to $488.09; and 400 shares sold at $488.52 to $489.50. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $480.67 to $489.28 as follows: 270 shares sold at $480.67 to $480.99; 100 shares sold at $483.59; and 72 shares sold at $489.28. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $478.45 to $490.19 as follows: 702 shares sold at $478.45 to $479.29; 1,330 shares sold at $480.41 to $481.13; 200 shares sold at $481.50 to $482.50; 500 shares sold at $482.76 to $483.03; 358 shares sold at $485.39 to $486.00; 2,377 shares sold at $487.20 to $488.09; 975 shares sold at $488.52 to $489.50; and 182 shares sold at $489.69 to $490.19. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F6 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.